Gayle Deflin, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 9,038 shares at $44.01 ($398K) on 2023-05-18, disclosed to the SEC on 2023-05-19.
Open-market sale of $398k AMPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.01 | 4,519 | $199K | 50.0% |
| 2 | $44.01 | 4,519 | $199K | 50.0% |
| Total | $44.01 avg | 9,038 | $398K | 100% |
| Filing → |